HIV/AIDS Clinical Care

HIV/AIDS Clinical Care

USPSTF Guide to Clinical Preventive Services, 2014

Recommendations of the U.S. Preventive Services Task Force

The U.S. Preventive Services Task Force offers a free pocket guide for all providers of primary care services. The clinical summaries are abridged versions of recommendations from the USPSTF.

HIV and ID Observations Blog

CDC Recommends Broader Use of Pre-Exposure Prophylaxis — Can We Make It Happen? Free

CDC is now recommending tenofovir/FTC (Truvada) for all Americans at high risk for HIV. Dr. Paul Sax offers his thoughts on the challenges ahead.

Guideline Watch

CDC Guidelines for Pre-Exposure Prophylaxis to Prevent HIV Infection

Daily oral tenofovir/FTC coupled with risk-reduction services and careful monitoring is recommended as one prevention option for high-risk men who have sex with men, heterosexuals, and injection-drug users.

Updated DHHS HIV Treatment Guidelines

This major revision includes a recommendation for less-frequent CD4-count monitoring, an updated list of recommended regimens, a discussion of “switching,“ and a new section on treatment costs.

Managing Drug Interactions in the Treatment of HIV-Associated TB

These updated guidelines provide recommendations for managing drug interactions between rifamycin antibiotics and four classes of antiretrovirals and for co-treatment of tuberculosis and HIV infection in children and pregnant women.

Prevention of Catheter-Associated Urinary Tract Infections

This document updates 2008 guidelines on prevention of catheter-associated urinary tract infections in acute care hospitals.

Drug Watch


The FDA has approved the integrase inhibitor dolutegravir for treatment of HIV infection, in combination with other antiretrovirals.